Himmel Pharmaceuticals has first taken place in the pharmaceutical sector in 2016 by introducing Anti-cancer products in Pakistan and become an exclusive distributor for the Reputable European companies. The company has extended its business line by introducing Contrast Media for better diagnosing of the disease. Himmel Pharma with the passage of time has gain confidence among KOLs of Oncology and Radiology segments. We specialize in the market expansion of innovative healthcare products. We understand the culture and work in the language of the markets we serve. The mission of our Company is to market and bring pharmaceutical healthcare products to patients with serious and/or life-threatening diseases. We partner and collaborate with innovators, delivering expedited product development and modern commercialization processes that assist with meeting critical endpoints, leveraging technology to shorten timelines, and employing learning resources to maintain high quality. Our therapeutic areas of expertise include oncology. Our in-depth expertise and capabilities focus on three key areas: Product Development, Commercialization, and Quality & Compliance. We have extensive practical experience from working in the Healthcare Industry, specifically in the areas of product, quality and compliance/Supply chain security, and global commercialization. Our management team includes professional experts in business development, marketing, sales, regulatory, Pharmacovigilance, Quality & Compliance. We provide companies with accessibility and market expansion in Pakistan. We are familiar with the key players in the market, including manufacturers, distributors, and major reimbursement entities product, etc.